Short or Long Antibiotic Regimens in Orthopedics
BACKGROUND: Orthopedic infection is usually managed with surgery and prolonged systemic antibiotic therapy. Whether local antibiotics delivered by a product implanted at the infection site during surgery can reduce the duration of systemic antibiotic therapy is unclear. METHODS: In a multicenter, open-label, noninferiority trial, we randomly assigned, in a 1:1 ratio, adults who had undergone surgery for orthopedic infection and implantation of a local-antibiotic carrier to receive postoperative systemic antibiotic therapy for a long (≥4 weeks) or short (≤7 days) duration. The primary outcome was definite treatment failure by 12 months, assessed according to protocol-defined criteria by a clinical end-point committee whose members were unaware of the trial-group assignments. The noninferiority margin was 10 percentage points. RESULTS: A total of 500 patients underwent randomization, of whom 475 were assessed in the primary analysis. Definite treatment failure occurred in 34 of 241 patients (14.1%) in the long-duration group and in 26 of 234 patients (11.1%) in the short-duration group (risk difference [negative values favor the short duration], -3.0 percentage points; 95% confidence interval [CI], -9.0 to 3.0), which met the prespecified noninferiority margin. In sensitivity analyses in the included population (497 patients) and the per-protocol population (457 patients), results were consistent with those of the primary analysis (risk difference, -2.4 percentage points [95% CI, -8.2 to 3.5] and -2.7 percentage points [95% CI, -8.8 to 3.4], respectively). By week 6 after surgery, symptoms potentially related to treatment had occurred in 45.2% of the patients in the long-duration group and in 17.2% of those in the short-duration group (risk difference, -28.0 percentage points; 95% CI, -36.4 to -19.6). CONCLUSIONS: Among patients who had undergone orthopedic surgery and received local antibiotics, a short course of systemic antibiotics was noninferior to a long course with respect to definite treatment failure by 12 months. (Funded by the European Bone and Joint Infection Society and others; SOLARIO ClinicalTrials.gov number, NCT03806166.).
Authors
- Simon Warren (ORCID: https://orcid.org/0000-0002-0568-0709)
- Antony Palmer (ORCID: https://orcid.org/0000-0003-4616-7482)
- B. Ollivere (ORCID: https://orcid.org/0000-0002-1410-1756)
- Abtin Alvand (ORCID: https://orcid.org/0000-0001-6069-978X)
- Daniel Pérez‐Prieto (ORCID: https://orcid.org/0000-0002-7112-0742)
- Alexis D. Iliadis
- Steve A. Jones
- Irene Katharina Sigmund (ORCID: https://orcid.org/0000-0002-5068-2738)
- Matthew Cichero (ORCID: https://orcid.org/0000-0002-8586-3459)
- Maria Dudareva (ORCID: https://orcid.org/0000-0002-3139-7237)
- O. Martin Williams (ORCID: https://orcid.org/0000-0002-6358-6307)
- Anand Pillai
- Andre D. Carvalho
- Matthew Scarborough (ORCID: https://orcid.org/0000-0002-0455-0785)
- Claire L. Scarborough
- Bernadette Young (ORCID: https://orcid.org/0000-0001-6071-6770)
- Werner Vach (ORCID: https://orcid.org/0000-0003-1865-8399)
- Michelle Kümin (ORCID: https://orcid.org/0000-0003-4618-6528)
- Adrian Kendal (ORCID: https://orcid.org/0000-0002-2208-0246)
- Sunil Sharma (ORCID: https://orcid.org/0000-0001-5892-2671)
- Bridget L. Atkins (ORCID: https://orcid.org/0000-0001-8778-0633)
- Andrew Bing (ORCID: https://orcid.org/0000-0002-4629-9971)
- Martin McNally (ORCID: https://orcid.org/0000-0003-2003-9044)
- Henry Wynn Jones (ORCID: https://orcid.org/0000-0002-9582-6117)
- Neil Jenkins
- Harriet Hughes (ORCID: https://orcid.org/0000-0002-6405-0731)
- Simon Ellis (ORCID: https://orcid.org/0000-0003-2502-3818)
- John Williams (ORCID: https://orcid.org/0000-0002-4809-4320)
- Amirul Islam (ORCID: https://orcid.org/0000-0003-2444-942X)
- Aaron Ng
- Adrian Taylor (ORCID: https://orcid.org/0000-0001-7521-8643)
- Neal Jacobs
- David A. Stubbs
- Reinhard Windhager
- Jamie Ferguson
- Michael J. Riste
- Andreas Leithner
- Alex J. Ramsden
- Ricardo Sousa
- Ben Kendrick
- Jonathan Folb
- Con L. Loizou
- Volker Alt
Institutions
- Cardiff and Vale University Health Board (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Medical University of Graz (AT)
- Barts Health NHS Trust (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- University Hospital of Wales (GB)
- Northumbria Healthcare NHS Foundation Trust (GB)
- Nuffield Orthopaedic Centre (GB)
- Wrightington, Wigan and Leigh NHS Foundation Trust (GB)
- Robert Jones and Agnes Hunt Orthopaedic Hospital (GB)
- Royal Liverpool and Broadgreen University Hospital NHS Trust (GB)
- South Tees Hospitals NHS Foundation Trust (GB)
- University Hospital Regensburg (DE)
- University of Oxford (GB)
- Manchester University NHS Foundation Trust (GB)
- Royal National Orthopaedic Hospital NHS Trust (GB)
- Hospital de Santo António (PT)
- Great Western Hospitals NHS Foundation Trust (GB)
- Nottingham Biomedical Research Centre (GB)
- University Hospitals Sussex NHS Foundation Trust (GB)
- Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust (GB)
- Hospital del Mar Research Institute (ES)
- Mid Yorkshire Hospitals NHS Trust (GB)
- University College London (GB)
- Medical University of Vienna (AT)
- Salisbury NHS Foundation Trust (GB)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2026-09-16
- DOI
- https://doi.org/10.1056/nejmoa2506756
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- British Medical Association